<DOC>
	<DOCNO>NCT02434627</DOCNO>
	<brief_summary>The investigator ' previous work male Becker Muscular Dystrophy show functional sympatholysis restore acute inorganic nitrate supplementation . This translated work use mdx mouse model dystrophinopathy . Recent work show frank improvement grip strength mdx mouse treat inorganic Nitric Oxide ( NO ) donor . The purpose study determine chronic treatment inorganic NO donor benefit patient muscular dystrophy beyond blood flow regulation .</brief_summary>
	<brief_title>Sodium Nitrate Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Clinical diagnosis muscular dystrophy Age 1545 year age Ambulatory No clinical evidence heart failure Maximum voluntary contraction , measure hand grip dynamometer , 2040 kg Hypertension , diabetes , heart failure standard clinical criterion Elevated Btype Natruiretic Peptide level ( &gt; 100 pg/ml ) Left Ventricular Ejection Fraction &lt; 50 % Wheelchair bound Cardiac rhythm disorder , specifically : rhythm sinus , Supraventricular Tachycardia , atrial fibrillation , ventricular tachycardia Continuous ventilatory support Liver disease Renal impairment Contraindications NO donor ( use nitrate , alphablockers , CYP3A inhibitor , amlodipine , Phosphodiesterase type 5 ( PDE5 ) inhibitor ) Glucocorticoid therapy prophylactic use Angiotensin Converting Enzyme ( ACE ) inhibitors betablockers cardiac protection exclusion criterion . Maximum voluntary contraction le 20 kg great 40 kg Ventilation Devices ( Continuous Positive Airway Pressure ( CPAP ) , Bilevel Positive Airway Pressure ( BiPAP ) )</criteria>
	<gender>Male</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Becker</keyword>
	<keyword>Dystrophy</keyword>
</DOC>